Literature DB >> 8363466

Central serous chorioretinopathy in endogenous hypercortisolism.

E A Bouzas1, M H Scott, G Mastorakos, G P Chrousos, M I Kaiser-Kupfer.   

Abstract

OBJECTIVE: To examine the potential association of central serous chorioretinopathy with endogenous hypercortisolism (Cushing's syndrome).
DESIGN: Ophthalmologic survey of consecutively admitted patients with endogenous Cushing's syndrome.
SETTING: An eye clinic of a research center (National Eye Institute, Bethesda, Md). PATIENTS: Sixty consecutive patients with confirmed endogenous Cushing's syndrome. MAIN OUTCOME MEASURES: Findings from complete ophthalmologic evaluation.
RESULTS: Three (5%) of 60 patients had one or more episodes of appropriately documented central serous chorioretinopathy. In all cases, the episodes occurred during the period of hypercortisolism.
CONCLUSIONS: Central serous chorioretinopathy is an uncommon manifestation of endogenous Cushing's syndrome. Since central serous chorioretinopathy has been associated with other hypercortisolemic states, we suggest that glucocorticoids may play a role in the development of this disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8363466     DOI: 10.1001/archopht.1993.01090090081024

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  50 in total

1.  Crohn's disease complicated by central serous retinopathy.

Authors:  G A Paspatis; P Koutentakis; K Triantafyllou; N Papanikolaoy; M Prinianaki; C Fanoyriakis
Journal:  Dig Dis Sci       Date:  2001-10       Impact factor: 3.199

2.  Central serous chorioretinopathy after inhaled steroid use for post-mycoplasmal bronchospasm.

Authors:  B Fardin; D J Weissgold
Journal:  Br J Ophthalmol       Date:  2002-09       Impact factor: 4.638

3.  Central serous chorioretinopathy.

Authors:  J M Jumper
Journal:  Br J Ophthalmol       Date:  2003-06       Impact factor: 4.638

Review 4.  [Ocular side effects and complications of intravitreal triamcinolone acetonide injection].

Authors:  G B Jaissle; P Szurman; K U Bartz-Schmidt
Journal:  Ophthalmologe       Date:  2004-02       Impact factor: 1.059

Review 5.  Central serous retinopathy associated with adrenocorticotrophic hormone therapy. A case report and a hypothesis.

Authors:  E Zamir
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-06       Impact factor: 3.117

6.  Morphological changes in the retinal pigment epithelium on spectral-domain OCT in the unaffected eyes with idiopathic central serous chorioretinopathy.

Authors:  Pawan Gupta; Vishali Gupta; M R Dogra; Ramandeep Singh; Amod Gupta
Journal:  Int Ophthalmol       Date:  2009-01-30       Impact factor: 2.031

7.  Ophthaproblem. Central serous chorioretinopathy.

Authors:  S Sharma
Journal:  Can Fam Physician       Date:  1998-09       Impact factor: 3.275

8.  Persistent unilateral central serous chorioretinopathy in a breastfeeding woman.

Authors:  Christine Elizabeth Lopez-Yang; Charles A Garcia
Journal:  BMJ Case Rep       Date:  2015-01-07

9.  En face enhanced-depth swept-source optical coherence tomography features of chronic central serous chorioretinopathy.

Authors:  Daniela Ferrara; Kathrin J Mohler; Nadia Waheed; Mehreen Adhi; Jonathan J Liu; Ireneusz Grulkowski; Martin F Kraus; Caroline Baumal; Joachim Hornegger; James G Fujimoto; Jay S Duker
Journal:  Ophthalmology       Date:  2013-11-26       Impact factor: 12.079

10.  Central serous chorioretinopathy in African Americans.

Authors:  Uday R Desai; Amir A Alhalel; Thomas J Campen; Rhett M Schiffman; Paul A Edwards; Gordon R Jacobsen
Journal:  J Natl Med Assoc       Date:  2003-07       Impact factor: 1.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.